Inhibition of mTOR Restores Corticosteroid Sensitivity in COPD

Share this content:
Inhibition of mTOR Restores Corticosteroid Sensitivity in COPD
Inhibition of mTOR Restores Corticosteroid Sensitivity in COPD

FRIDAY, Jan. 22, 2016 (HealthDay News) -- Inhibition of mammalian target of rapamycin (mTOR) by rapamycin restores corticosteroid sensitivity in patients with chronic obstructive pulmonary disease (COPD), according to a study published in the Jan. 15 issue of the American Journal of Respiratory and Critical Care Medicine.

Akihisa Mitani, M.D., Ph.D., from Imperial College London, and colleagues examined the role of mTOR in corticosteroid sensitivity in COPD. Corticosteroid sensitivity was assessed in peripheral blood mononuclear cells obtained from patients with COPD, smokers, and nonsmoking controls, as well as in human monocytic U937 cells exposed to cigarette smoke extract (CSE), in the presence and absence of the mTOR inhibitor rapamycin.

The researchers observed increased mTOR activity in peripheral blood mononuclear cells from patients with COPD, which was inhibited by rapamycin treatment. Rapamycin treatment also restored corticosteroid sensitivity. CSE stimulated mTOR activity and c-Jun expression in U937 cells; rapamycin pretreatment inhibited both and reversed corticosteroid insensitivity induced by CSE.

"mTOR inhibition by rapamycin restores corticosteroid sensitivity via inhibition of c-Jun expression, and thus mTOR is a potential novel therapeutic target for COPD," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »